1
TITLE: Subgroup analyses results of the PETACC8 phase III trial comparing adjuvant FOLFOX4 with or without cetuximab (CTX) in resected stage III colon cancer (CC).
AUTHORS: Julien Taieb; Josep Tabernero; Enrico Mini; Fabien Subtil; Gunnar Folprecht; Jean Luc Van Laethem; Joseph Thaler; John A Bridgewater; Evaristo Sanches; Lone Petersen; Laurence Collette; Eric Van Cutsem; Karine Le Malicot; Philippe Rougier; Ramon Salazar; Laurent Bedenne; Jean Francois Emile; Pierre Laurent Puig; Come Lepage;
PUBLISHED: 2013, SOURCE: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, ISSUE: 15
INDEXED IN: WOS
2
TITLE: ADJUVANT FOLFOX4+/- CETUXIMAB IN KRAS WILD-TYPE PATIENTS WITH RESECTED STAGE III COLON CANCER RESULTS FROM THE PETACC8 INTERGROUP TRIAL
AUTHORS: Julien Taieb; Josep Tabernero; Enrico Mini; Fabien Subtil; Gunnar Folprecht; Jean Luc Van Laethem; Josef Thaler; John Bridgewater; Evaristo Sanches; Lone Norgard Petersen; Philippe Rougier; Laurence Collette; Michel Praet; Cecile Girault; Martina Schneider; Pierre Squifflet; Pierre Laurent Puig; Eric Van Cutsem; Laurent Bedenne; Come Lepage;
PUBLISHED: 2012, SOURCE: 14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 23
INDEXED IN: WOS
3
TITLE: Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer  Full Text
AUTHORS: Pedro Pinto; Patricia Rocha; Isabel Veiga; Joana Guedes; Manuela Pinheiro; Ana Peixoto; Carla Pinto; Maria Fragoso; Evaristo Sanches; Antonio Araujo ; Fernando Alves; Camila Coutinho; Paula Lopes; Rui Henrique ; Manuel R Teixeira ;
PUBLISHED: 2011, SOURCE: CANCER GENETICS, VOLUME: 204, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 31
4
TITLE: Raltitrexed (Tomudex (R)) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)  Full Text
AUTHORS: Ivan Popov; Alfredo Carrato; Alberto Sobrero; Mark Vincent; David Kerr; Roberto Labianca; Angelo Raffaele Bianco; Mostafa El Serafi; Laurent Bedenne; Bernard Paillot; Enrico Mini; Evaristo Sanches; John Welch; Laurence Collette; Michel Praet; Jacques Wils;
PUBLISHED: 2008, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 44, ISSUE: 15
INDEXED IN: Scopus WOS CrossRef
5
TITLE: Irinotecan (Iri) plus docetaxel (Doc) every 3 weeks in chemotherapy naive patients (pts) with inoperable non-small cell lung cancer (NSCLC): results of a phase II study
AUTHORS: Reiner Bonnet; Rafael Roseli; Janos Strausz; Evaristo Sanches; Mariano Provencio; Jean Marc Vernejoux; Herve Lena; Michael L Gershanovich; Blandine Boussard; Joachim von Pawel;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15
INDEXED IN: WOS